IXHLIncannex Healthcare Limited American Depositary Shares

NAS · US · Healthcare · Drug Manufacturers - Specialty & Generic · incannex.com

3.570USDMkt Cap: 42.71M $P/E: —3d ago

Incannex Healthcare Inc., a clinical-stage biopharmaceutical company, engages in the research and development of psychedelic medicines and therapies for patients with chronic diseases in Australia. The company develops I…

Industry Peers

Drug Manufacturers - Specialty & Generic

Screen all

MRK

MERCK Kommanditgesellschaft auf Aktien

$65.19BUSDP/E 23.7

TAK

Takeda Pharmaceutical Co. Ltd.

$58.06BUSD

HLN

Haleon plc American Depositary Shares (Each representing two Ordinary Shares)

$43.98BUSDP/E 20.4

TEVA

Teva Pharmaceutical Industries Limited

United Therapeutics Corporation

Swedish Orphan Biovitrum AB

Neurocrine Biosciences, Inc.

$15.51BUSDP/E 22.3

ELAN

Elanco Animal Health Incorporat

$11.98BUSD

RDY

Dr. Reddy's Laboratories Ltd

Hims & Hers Health, Inc.

$7.88BUSD

LNTH

Lantheus Holdings Inc

$6.53BUSDP/E 23.9

AMRX

Amneal Pharmaceuticals, Inc. Class A

Kiniksa Pharmaceuticals, Ltd.

$6.08BUSDP/E 79.8

Key Statistics

Company

Market Cap42.71M $

Enterprise Value-33.18M $

Revenue (TTM)0 $

Gross Profit0 $

Net Income (TTM)-48.41M $

Revenue/Share0.0000 USD

Last Price3.570 USD

Fiscal Year EndJun 2025

MR QuarterMar 2026

Employees12

CountryUS

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)-2.13

PEG—

EV/EBITDA1.34

EV/Revenue—

P/SInfinity

P/B0.66

EPS (TTM)-16.62

EPS (Forward)-1.70

52W Range

3.51441% of range3.650

52W High3.650 USD

52W Low3.514 USD

Profitability

Gross Margin0.00%

Oper. Margin0.00%

EBITDA Margin0.00%

Profit Margin0.00%

ROE-117.17%

ROA-32.19%

Growth

Revenue Growth—

Earnings Growth—

Cash Flow & Leverage

Operating CF-15.85M $

CapEx (TTM)277.00K $

FCF Margin—

FCF Yield-19.37%

Net Debt-74.34M $

Net Debt/EBITDA3.01

Balance Sheet

Debt/Equity0.15

Current Ratio41.56

Quick Ratio41.47

Book Value/Sh5.498 USD

Cash/Share6.223 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Splits

Last Split1:30

Split DateFeb 27, 2026

Analyst Consensus

Rating—

Target (Mean)18.14 USD

Upside (mean)+408.1%

Target Range18.14 USD – 18.14 USD

# Analysts1

Ownership

Shares Out.11.96M

Float9.60M

Insiders12.34%

Institutions3.81%

Short Interest

Short Ratio5.0d

Short % Float7.49%

Short % Out.7.39%

Shares Short884.66K

Short (prev mo.)509.08K

Technical

SMA 503.341 (+6.9%)

SMA 2006.323 (-43.5%)

Beta2.81

S&P 52W Chg21.00%

Avg Vol (30d)69.76K

Avg Vol (10d)89.02K

Technical Indicators

RSI (14)66.0

MACD0.0649

MACD Signal-0.0047

MACD Hist.+0.0696

BB Upper3.595 USD

BB Middle3.166 USD

BB Lower2.737 USD

BB Width27.11%

ATR (14)0.1757 USD

Vol Ratio (20d)0.77x